These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 26911375)

  • 1. Prevalence and phenotypic correlations of EIF1AX mutations in thyroid nodules.
    Karunamurthy A; Panebianco F; J Hsiao S; Vorhauer J; Nikiforova MN; Chiosea S; Nikiforov YE
    Endocr Relat Cancer; 2016 Apr; 23(4):295-301. PubMed ID: 26911375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EIF1AX mutation in thyroid tumors: a retrospective analysis of cytology, histopathology and co-mutation profiles.
    Elsherbini N; Kim DH; Payne RJ; Hudson T; Forest VI; Hier MP; Payne AE; Pusztaszeri MP
    J Otolaryngol Head Neck Surg; 2022 Nov; 51(1):43. PubMed ID: 36371345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TERT, HRAS, and EIF1AX Mutations in a Patient with Follicular Adenoma.
    Topf MC; Wang ZX; Tuluc M; Pribitkin EA
    Thyroid; 2018 Jun; 28(6):815-817. PubMed ID: 29669480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological features and outcomes of thyroid nodules with EIF1AX mutations.
    Karslioglu French E; Nikitski AV; Yip L; Nikiforova MN; Nikiforov YE; Carty SE
    Endocr Relat Cancer; 2022 Aug; 29(8):467-473. PubMed ID: 35609001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EIF1AX c.338-2A>T splice site mutation in a patient with trabecular adenoma and cytological indeterminate lesion.
    Castagna MG; Pilli T; Maino F; Marzocchi C; Cairano GD; Cantara S
    Arch Endocrinol Metab; 2020 Apr; 64(2):185-189. PubMed ID: 32236306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization and Clinical Significance of EIF1AX Mutations and Co-Mutations in Cytologically Indeterminate Thyroid Nodules: A 5-Year Retrospective Analysis.
    Gargano SM; Badjatia N; Nikolaus Y; Peiper SC; Wang ZX
    Acta Med Acad; 2021 Apr; 50(1):4-12. PubMed ID: 34075760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Highly accurate diagnosis of cancer in thyroid nodules with follicular neoplasm/suspicious for a follicular neoplasm cytology by ThyroSeq v2 next-generation sequencing assay.
    Nikiforov YE; Carty SE; Chiosea SI; Coyne C; Duvvuri U; Ferris RL; Gooding WE; Hodak SP; LeBeau SO; Ohori NP; Seethala RR; Tublin ME; Yip L; Nikiforova MN
    Cancer; 2014 Dec; 120(23):3627-34. PubMed ID: 25209362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absence of EIF1AX, PPM1D, and CHEK2 mutations reported in Thyroid Cancer Genome Atlas (TCGA) in a large series of thyroid cancer.
    Alzahrani AS; Murugan AK; Qasem E; Alswailem MM; AlGhamdi B; Moria Y; Al-Hindi H
    Endocrine; 2019 Jan; 63(1):94-100. PubMed ID: 30269267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical utility of EZH1 mutations in the diagnosis of follicular-patterned thyroid tumors.
    Jung CK; Kim Y; Jeon S; Jo K; Lee S; Bae JS
    Hum Pathol; 2018 Nov; 81():9-17. PubMed ID: 29723601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EIF1AX Mutation in a Patient with Hürthle Cell Carcinoma.
    Topf MC; Wang ZX; Furlong K; Miller JL; Tuluc M; Pribitkin EA
    Endocr Pathol; 2018 Mar; 29(1):27-29. PubMed ID: 28965201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient with multiple genetically distinct thyroid nodules including papillary thyroid carcinoma harboring novel YWHAG-BRAF fusion.
    Lin R; Wang ZX; Cottrill E; Badjatia N; Gargano SM
    Cancer Genet; 2022 Aug; 266-267():51-56. PubMed ID: 35780657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pyrosequencing analysis for detection of a BRAFV600E mutation in an FNAB specimen of thyroid nodules.
    Kim SK; Kim DL; Han HS; Kim WS; Kim SJ; Moon WJ; Oh SY; Hwang TS
    Diagn Mol Pathol; 2008 Jun; 17(2):118-25. PubMed ID: 18382358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of molecular testing in fine-needle aspiration biopsy samples: an experience in a Chinese population.
    Liu S; Gao A; Zhang B; Zhang Z; Zhao Y; Chen P; Ji M; Hou P; Shi B
    Exp Mol Pathol; 2014 Oct; 97(2):292-7. PubMed ID: 25111330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ROLE OF MOLECULAR MARKERS IN THYROID NODULE MANAGEMENT: THEN AND NOW.
    Nikiforov YE
    Endocr Pract; 2017 Aug; 23(8):979-988. PubMed ID: 28534687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Centralized molecular testing for oncogenic gene mutations complements the local cytopathologic diagnosis of thyroid nodules.
    Beaudenon-Huibregtse S; Alexander EK; Guttler RB; Hershman JM; Babu V; Blevins TC; Moore P; Andruss B; Labourier E
    Thyroid; 2014 Oct; 24(10):1479-87. PubMed ID: 24811481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of EIF1AX in thyroid cancer tumourigenesis and progression.
    Simões-Pereira J; Moura MM; Marques IJ; Rito M; Cabrera RA; Leite V; Cavaco BM
    J Endocrinol Invest; 2019 Mar; 42(3):313-318. PubMed ID: 29968046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uncommon BRAF mutations in the follicular variant of thyroid papillary carcinoma: New insights.
    Rossi ED; Martini M; Bizzarro T; Capodimonti S; Cenci T; Lombardi CP; Pontecorvi A; Fadda G; Larocca LM
    Cancer Cytopathol; 2015 Oct; 123(10):593-602. PubMed ID: 26230187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can TP53-mutant follicular adenoma be a precursor of anaplastic thyroid carcinoma?
    Nikitski AV; Nikiforova MN; Yip L; Karslioglu-French E; Carty SE; Nikiforov YE
    Endocr Relat Cancer; 2021 Aug; 28(9):621-630. PubMed ID: 34264855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathologic Characteristics of Thyroid Nodules Positive for the
    Morariu EM; McCoy KL; Chiosea SI; Nikitski AV; Manroa P; Nikiforova MN; Nikiforov YE
    Thyroid; 2021 Aug; 31(8):1212-1218. PubMed ID: 33487086
    [No Abstract]   [Full Text] [Related]  

  • 20. The diagnostic application of RNA sequencing in patients with thyroid cancer: an analysis of 851 variants and 133 fusions in 524 genes.
    Pagan M; Kloos RT; Lin CF; Travers KJ; Matsuzaki H; Tom EY; Kim SY; Wong MG; Stewart AC; Huang J; Walsh PS; Monroe RJ; Kennedy GC
    BMC Bioinformatics; 2016 Jan; 17 Suppl 1(Suppl 1):6. PubMed ID: 26818556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.